Edwards Lifesciences Corporation (EW)

NYSE · Healthcare · Medical Devices
$101.85-1.95%As of 2026-11-22 · USD
Last session low $101.66Last session high $104.92
52-week low $74.6652-week high $108.00
Market cap
$58.56B
Sector
Healthcare
P/E (TTM)
59.2x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)64.7In the neutral range (30 to 70)
MACD (12, 26, 9)4.12Below its signal line (4.21); histogram -0.09
Bollinger %B (20, 2)57%Inside the bands (88.31 to 111.98)
SMA 20100.15Price is 1.7% above
SMA 5092.25Price is 10.4% above
SMA 20086.94Price is 17.1% above
ATR (20)2.65% of priceAverage true range per day
52-week position82%In the upper part of the 74.66 to 108.00 range

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.

Insider filings, 90 daysNo purchases and 9 sales (about $10.9M).
Latest fiscal yearEnded 2025-12-31: revenue of $6.07B and an operating margin of 27.0%.

More in Medical Devices